The 2^nd International Symposium on Kallikreins and Kallikrein-Related Peptidases (ISK 2007) and the Commemorative Gold Medal of the E.K. Frey–E. Werle Foundation of the Henning L. Voigt Family

Artikel in diesem Heft

1. Editorial
2. Kallikreins and kallikrein-related peptidases
3. Guest Editorial
4. The 2^nd International Symposium on Kallikreins and Kallikrein-Related Peptidases (ISK 2007) and the Commemorative Gold Medal of the E.K. Frey–E. Werle Foundation of the Henning L. Voigt Family
5. Highlight: Kallikrein, kinins and kallikrein-related peptidases
6. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
7. Development of peptides specifically modulating the activity of KLK2 and KLK3
8. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer
9. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
10. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
11. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology
12. microRNAs: a new frontier in kallikrein research
13. Functions of KLK4 and MMP-20 in dental enamel formation
14. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney
15. Development of diabetic cardiomyopathy and the kallikrein-kinin system – new insights from B1 and B2 receptor signaling
16. Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor
17. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model
18. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia
19. Kallikreins as microRNA targets: an in silico and experimental-based analysis
20. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration
21. Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids
22. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
23. Gene expression changes associated with the anti-angiogenic activity of kallikrein-related peptidase 3 (KLK3) on human umbilical vein endothelial cells
24. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines
25. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung